Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J. S. Kroin"'
Autor:
V, Gluncic, M, Moric, Y, Chu, V, Hanko, J, Li, I K, Lukić, A, Lukić, S L, Edassery, J S, Kroin, A L, Persons, P, Perry, L, Kelly, T J, Shiveley, K, Nice, T C, Napier, J H, Kordower, K J, Tuman
Publikováno v:
Cerebral Cortex. 30:5190-5190
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 15(6)
The prototypic motor feature of Huntington's disease (HD) is chorea, but parkinsonism and involuntary movements such as dystonia and myoclonus can also be present. Pallidotomy has been shown to be an effective treatment for medically refractory Parki
Publikováno v:
Neurosurgery. 46(1)
Although corticosteroids have been used intraspinally for many years, long-term intrathecal administration has not been examined. We have assessed the stability, bioavailability, and safety of continuously delivering the prodrug dexamethasone sodium
Autor:
W J, Ehlhardt, J M, Woodland, T M, Baughman, M, Vandenbranden, S A, Wrighton, J S, Kroin, B H, Norman, S R, Maple
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 26(1)
Compound LY335979 is a P-glycoprotein inhibitor currently entering phase I clinical trials for potential reversal of multidrug resistance to cancer chemotherapy. In early exploratory studies, LY335979 was found to be rapidly transformed in incubation
Publikováno v:
Neurologia medico-chirurgica. 37(1)
The effects of the intrathecal alpha 2-agonists tizanidine and clonidine and the somatostatin analog octreotide on an experimental rat model of tactile allodynia were investigated to determine the therapeutic potential for treating chronic neuropathi
Publikováno v:
The Journal of comparative neurology. 375(3)
Brain-derived neurotrophic factor (BDNF) was the second member of the nerve growth factor (NGF) family to be isolated. The ability of BDNF to be retrogradely transported following intraparenchymal infusion represents a unique neurobiological tool to
Autor:
L. W. Hertel, J. S. Kroin, C. S. Grossman, Gerald B. Grindey, A. F. Dorr, A. M. V. Storniolo, W. Plunkett, V. Gandhi, P. Huang
Publikováno v:
ACS Symposium Series ISBN: 9780841234420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe7ca1bf8193ffbcbb54450fc1c52255
https://doi.org/10.1021/bk-1996-0639.ch019
https://doi.org/10.1021/bk-1996-0639.ch019
Publikováno v:
Cancer research. 53(19)
Gemcitabine [2',2'-difluorodeoxycytidine (dFdCyd)], a potent antitumor agent, inhibits DNA synthesis and is incorporated internally into DNA. The effect of a template-incorporated dFdCyd molecule (dFdCyd-) on DNA polymerase function was examined. Two
Publikováno v:
Neurosurgery. 33(2)
Chronic intrathecal drug infusion for the treatment of neurological diseases, such as spasticity and chronic pain, has become an accepted method of therapy in recent years. Concurrent pharmacokinetic studies have shown that the cisternal cerebrospina
Publikováno v:
Oncology research. 5(2)
2',2'-Difluorodeoxycytidine (Gemcitabine, dFdCyd) is a cytotoxic agent which is active toward a variety of tumor cells. It has been shown that there are multiple intracellular sites of action which include ribonucleotide reductase and DNA polymerase.